A new study further supports the use of radiotherapy in the treatment of retroperitoneal sarcoma. The finding comes from two large case-control analyses of 9068 patients with localized primary ...
We identified 276 patients with primary retroperitoneal WDLS and 353 patients with primary retroperitoneal DDLS who underwent resection between July 1982 and July 2021 at our institution. WDLS ...
Survivin-responsive conditionally replicating adenovirus for patients with advanced sarcoma demonstrated potent and long-term efficacy and high safety in a phase I clinical trial. Trabectedin and ...
Fragmented care — receiving medical treatment at more than one facility — has been associated with both positive and negative outcomes for cancer patients depending on a number of factors such as ...
Fragmented care - receiving medical treatment at more than one facility - has been associated with both positive and negative outcomes for cancer patients depending on a number of factors such as ...
Only one retroperitoneal sarcoma (RPS) patient out of 22 achieved meaningful tumor shrinkage with pre-surgical radiation, while over 75% of the sample saw no significant change and 18% experienced ...
Please provide your email address to receive an email when new articles are posted on . A phase 2 trial conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated the ...
In this video, Chandrajit Raut, MD, MS, discussed results from the first study using a registry trying to “raise the quality of surgery” for retroperitoneal sarcomas, which was presented at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results